Advertisement
Screener

MiNK Therapeutics, Inc. (INKT) ROA

MiNK Therapeutics, Inc. (INKT) ROA

  • 2026-06-30: ROA -118.15%.
  • 2026-03-31: ROA -120.17%.
  • 2025-12-31: ROA -87.75%.
  • 2025-09-30: ROA -82.57%.

Complete source-backed roa history.

Available history
2020-12-31 to 2026-06-30
Data captured

Historical ROA

DateROA
2026-06-30-118.15%
2026-03-31-120.17%
2025-12-31-87.75%
2025-09-30-82.57%
2025-06-30-453.79%
2025-03-31-228.20%
2024-12-31-188.52%
2024-09-30-186.86%
2024-06-30-165.54%
2024-03-31-298.60%
2023-12-31-493.33%
2023-09-30-331.95%
2023-06-30-214.54%
2023-03-31-156.13%
2022-12-31-130.36%
2022-09-30-102.86%
2022-06-30-109.01%
2022-03-31-94.47%
2021-12-31-75.08%
2021-09-30-637.25%
2020-12-31-356.49%

Annual ROA

DateROA
2025-12-31-87.75%
2024-12-31-188.52%
2023-12-31-493.33%
2022-12-31-130.36%
2021-12-31-75.08%
2020-12-31-356.49%

Similar stocks

Stock NameCountryMarket CapPE Ratio
Eloxx Pharmaceuticals, Inc. (ELOX)United States$0.065B
EXOZYMES INC. (EXOZ)United States$0.058B
BioAtla, Inc. (BCAB)United States$0.058B-0.21
ImageneBio, Inc. (IMA)United States$0.056B-1.31
BioStem Technologies, Inc. (BSEM)United States$0.069B
CHAMPIONS ONCOLOGY, INC. (CSBR)United States$0.070B-68.02
Inmune Bio, Inc. (INMB)United States$0.056B-2.48
Kalaris Therapeutics, Inc. (KLRS)United States$0.073B-2.19
Tevogen Inc. (TVGN)United States$0.049B
Instil Bio, Inc. (TIL)United States$0.048B-1.73